Analysis of the treatment of neuromyelitis optica
- 1 April 2015
- journal article
- research article
- Published by Elsevier in Journal of the Neurological Sciences
- Vol. 351 (1-2), 31-35
- https://doi.org/10.1016/j.jns.2015.02.012
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Molecular Pathogenesis of Neuromyelitis OpticaInternational Journal of Molecular Sciences, 2012
- Neuromyelitis Optica: An Antibody-Mediated Disorder of the Central Nervous SystemNeurology Research International, 2012
- Treatment of neuromyelitis optica: an evidence based reviewArquivos de Neuro-Psiquiatria, 2012
- Impact of rituximab on relapse rate and disability in neuromyelitis opticaMultiple Sclerosis Journal, 2011
- Neuromyelitis optica: An updateJournal of the Neurological Sciences, 2011
- Current and future treatment approaches for neuromyelitis opticaTherapeutic Advances in Neurological Disorders, 2011
- Review: Treatment of neuromyelitis optica: Current debateTherapeutic Advances in Neurological Disorders, 2008
- Immunosuppressive therapy is more effective than interferon in neuromyelitis opticaMultiple Sclerosis Journal, 2007
- A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosisThe Lancet, 2004
- The clinical course of neuromyelitis optica (Devic’s syndrome)Neurology, 1999